Osteosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.
|
30886151 |
2019 |
Osteosarcoma of bone
|
0.020 |
Biomarker
|
disease |
BEFREE |
Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.
|
30886151 |
2019 |
Childhood Osteosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.
|
30886151 |
2019 |
Malignant Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
LIMK2 inhibition or ablation is therefore an alternative approach for modulating Aurora A deregulation in cancer.
|
22492986 |
2012 |
Primary malignant neoplasm
|
0.030 |
Biomarker
|
group |
BEFREE |
LIMK2 inhibition or ablation is therefore an alternative approach for modulating Aurora A deregulation in cancer.
|
22492986 |
2012 |
Colorectal Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
LIMK2 expression was reduced in intestinal tumours of cancer-prone mice, as well as in human CRC cell lines and tumours.
|
23585469 |
2014 |
Neoplasms
|
0.050 |
GeneticVariation
|
group |
BEFREE |
Limk2 deletion increased colon tumour size in a colitis-associated colorectal mouse cancer model.
|
23585469 |
2014 |
Colitis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Limk2 deletion increased colon tumour size in a colitis-associated colorectal mouse cancer model.
|
23585469 |
2014 |
Malignant Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
Limk2 deletion increased colon tumour size in a colitis-associated colorectal mouse cancer model.
|
23585469 |
2014 |
Primary malignant neoplasm
|
0.030 |
Biomarker
|
group |
BEFREE |
Limk2 deletion increased colon tumour size in a colitis-associated colorectal mouse cancer model.
|
23585469 |
2014 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
LIMK2 overexpression promoted proliferation, migration and invasion of BC cells, while LIMK2 depletion inhibited cell invasion and viability and induced growth arrest in vitro and in vivo.
|
30006972 |
2019 |
Intellectual Disability
|
0.010 |
Biomarker
|
group |
BEFREE |
LIMK2-1 is a Hominidae-Specific Isoform of LIMK2 Expressed in Central Nervous System and Associated with Intellectual Disability.
|
30594563 |
2019 |
Kidney Failure, Chronic
|
0.010 |
Biomarker
|
disease |
BEFREE |
A combined analysis of all 2890 patients with ESRD showed significant association SNPs in LIMK2 and SFI1 suggesting that they also contribute to all-cause ESRD.
|
21150874 |
2011 |
Chronic kidney disease stage 5
|
0.010 |
Biomarker
|
disease |
BEFREE |
A combined analysis of all 2890 patients with ESRD showed significant association SNPs in LIMK2 and SFI1 suggesting that they also contribute to all-cause ESRD.
|
21150874 |
2011 |
Diabetic Nephropathy
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
A genome-wide association study for diabetic nephropathy genes in African Americans.
|
21150874 |
2011 |
Diabetic Nephropathy
|
0.110 |
Biomarker
|
disease |
BEFREE |
Although genome-wide significance with type 2 diabetes was not found for any of these 25 SNPs, several genes, including RPS12, LIMK2, and SFI1 are strong candidates for diabetic nephropathy.
|
21150874 |
2011 |
Fibrosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Analyses of cellular phenotypes such as cell proliferation, cell migration and colony-forming efficiency revealed that the suppression of LIMK-2 expression in human fibrosarcoma cells limits their migration and dense colony-forming efficiency without affecting cell proliferation rate or viability.
|
15026997 |
2004 |
Adult Fibrosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Analyses of cellular phenotypes such as cell proliferation, cell migration and colony-forming efficiency revealed that the suppression of LIMK-2 expression in human fibrosarcoma cells limits their migration and dense colony-forming efficiency without affecting cell proliferation rate or viability.
|
15026997 |
2004 |
Carcinogenesis
|
0.030 |
GeneticVariation
|
phenotype |
BEFREE |
As the mechanisms of LIMK-associated tumorigenesis are still unclear, we analyzed the tumorigenic functions of LIM kinase 2 (LIMK2) in human bladder cancer (BC) and explored whether the newly identified LIMK2 3´-UTR SNP rs2073859 (G-to-A allele) is correlated with clinical features.
|
30006972 |
2019 |
Tumor Cell Invasion
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
Based on our findings, we suggest that cofilin-1 is crucial to switching from epithelial to mesenchymal-like morphology and cell migration and invasion by regulating actin cytoskeleton organization through activation of RhoA-LIMK2-cofilin-1 signaling, impacting the cell-cell adhesion organization of colon cancer cells in EMT.
|
30296500 |
2019 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.
|
28938584 |
2017 |
Neoplasm Metastasis
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.
|
28938584 |
2017 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
Both LIMK1 and LIMK2 single knock down led to a reduction of invasion and metastatic behavior in the zebrafish xenograft metastasis assay.
|
20047470 |
2009 |
Neoplasm Metastasis
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
Both LIMK1 and LIMK2 single knock down led to a reduction of invasion and metastatic behavior in the zebrafish xenograft metastasis assay.
|
20047470 |
2009 |
Erectile dysfunction
|
0.010 |
Biomarker
|
disease |
BEFREE |
Chronic administration of LIMK2 inhibitors alleviates cavernosal veno-occlusive dysfunction through suppression of cavernosal fibrosis in a rat model of erectile dysfunction after cavernosal nerve injury.
|
30870492 |
2019 |